Healthcare & Insurance
Teleflex Incorporated Announces Worldwide Recall of Arrow-Trerotola™ Over-The-Wire PTD® Kit Percutaneous Thrombolytic Device: 7FR
WAYNE, Pa., Nov. 26, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced a worldwide recall of Arrow-Trerotola™ Over-The-Wire PTD® Kit Percutaneous Thrombolytic Device: 7FR. The
Friday, November 26, 2021
Psyence Group Inc. files Q2 Unaudited Condensed Consolidated Interim Financial Statements and MD&A
TORONTO, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology company with a focus on natural psychedelics in mental health and well-being, announces that the Unaudited Condensed Consolidated Interim
Friday, November 26, 2021
Akero Therapeutics to Present at the Evercore ISI 4th Annual HealthCONx Virtual Conference
SOUTH SAN FRANCISCO, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today announced that management will participate in a
Friday, November 26, 2021
Assure Announces $435,000 Private Placement with Management and Board Participation
DENVER, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM; TSXV: IOM), a provider of intraoperative neuromonitoring services, is pleased to announce that the Company intends to complete a non-brokered private placement, with participation by
Friday, November 26, 2021
Information on the total number of voting rights and shares
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), November 26, 2021, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext
Friday, November 26, 2021
“Olainfarm” unaudited consolidated financial statement of the 9-month interim period of 2021
“Olainfarm” unaudited consolidated financial statement of the 9-month interim period of 2021 In the nine months of 2021, the Group's activity was still affected by the Covid-19 pandemic, but most of the business segments have nevertheless performed well. In the first nine months
Friday, November 26, 2021
AnPac Bio Reports Nine Months Ended September 30, 2021, Same Period Achieved Record Revenue Increased By 55.3% While Non-GAAP Net Loss Reduced by 6.8%
PHILADELPHIA, Nov. 26, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today its unaudited financial results for the nine months ended
Friday, November 26, 2021
Theratechnologies Named Recipient of the 2021 ADRIQ Innovation Award in the "Life Sciences" Category
MONTREAL, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that it was awarded of the 2021 Innovation
Friday, November 26, 2021
Psyence Group Invited as First Psychedelic Company to present at the 15th-Annual Global Wellness Summit
TORONTO, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology company with a focus on natural psychedelics in mental health and well-being, will break new ground as the first psychedelic company invited
Friday, November 26, 2021
NRx Pharmaceuticals Notes New Data on BriLife® COVID-19 Vaccine Effectiveness Against Delta Variant Posted by Israel Institute for Biological
Analysis of Blood Samples from Patients who Responded to the BriLife® Vaccine During Phase 2 Trial Suggests that the Same Level of Response was Seen Against the Delta Variant as Against the Original “Wild-Type” VirusData Suggest that the BriLife Vaccine May Be Capable of Evolving to Counter
Friday, November 26, 2021
Ozop Energy Solutions and Hyde Engineering to Bring Neo-Grid to Market
OZOP Prepares to Launch the Patent Pending Neo Grid proof of concept Florida, NY, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Ozop Energy Solutions. (OZSC), (“Ozop” or the “Company”), announces that after several months of analyzing the developmental direction of the energy markets and defining
Friday, November 26, 2021
Ocugen, Inc. Provides an Update on its Investigational New Drug Application with U.S. FDA to Initiate a Phase 3 Clinical Trial Evaluating COVID-19
MALVERN, Pa., Nov. 26, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics and vaccines, announced that the U.S. Food and Drug Administration (FDA) has issued a clinical hold on the
Friday, November 26, 2021
MediPharm Labs Completes Medical Cannabis Export to Barbados
Patient based delivery of medical cannabis executed with approval from both Barbados and Canadian Health Authorities.This marks the fourth new country entered by MediPharm Labs in 2021, following initial shipments to Germany, Brazil and Peru. BARRIE, Ontario, Nov. 26, 2021 (GLOBE NEWSWIRE) --
Friday, November 26, 2021
Comment on the interview for the journal Dienas Bizness
Comment on the interview for the journal Dienas Bizness The Management Board of “Olainfarm” got acquainted with the interview with Roberts Tavjevs, Member of the Board of the largest shareholder AS “AB CITY”, who controls 50.93% of the company's voting capital, for the journal Dienas
Friday, November 26, 2021
Bavarian Nordic A/S - Articles of Association
Updated Articles of Association for Bavarian Nordic A/S. Attachment Bavarian Nordic - Articles of Association
Friday, November 26, 2021
Roche Extraordinary General Meeting 2021
All proposals of the Board of Directors approved Audited statutory interim financial statements (standalone financial statements) of the Company as of 31 October 2021 approved Share capital reduction by cancellation of 53,309,000 bearer shares with a nominal value of CHF 1 each approved Basel, 26
Friday, November 26, 2021
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
COPENHAGEN, Denmark, November 26, 2021 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been increased by nominally DKK 295,960 as a consequence of employees’ exercise of warrants. The capital increase was effected without any pre-emption rights for the
Friday, November 26, 2021
Sampo plc’s share buybacks 25/11/2021
SAMPO PLC STOCK EXCHANGE RELEASE 26/11/2021 at 08:30 am Sampo plc’s share buybacks 25/11/2021 On 25/11/2021 Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as
Friday, November 26, 2021
Novo Nordisk announces impact from Volume Based Procurement for insulin in China
Bagsværd, Denmark, 26 November 2021 – Novo Nordisk today announced that the company has received the results from the Volume Based Procurement (VBP) tender for insulin in China. The Chinese National Healthcare Security Administration has tendered insulin sold at hospitals, and Novo Nordisk has
Friday, November 26, 2021
Clover’s COVID-19 Vaccine Candidate Administered as Heterologous Booster in Investigator-Led Phase 2 Clinical Trial
The Phase 2 trial will evaluate SCB-2019 (CpG 1018/Alum) as a booster dose in individuals previously vaccinated with CoronaVac or recombinant Covid-19 vaccine (AstraZeneca/Fiocruz) The Phase 2 trial is an investigator initiated study, sponsored by the Instituto D’Or de Pesquisa e Ensino (IDOR)
Friday, November 26, 2021
